Best Practices for Designing Informative Trials Including Women

Johny Nicolas, Madison Edens, Birgit Vogel, Roxana Mehran

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Purpose of Review: Despite mandates from funding agencies and professional societies to broaden inclusivity in medical research, women remain underrepresented in cardiovascular clinical trials. This lack of representation limits the generalizability of the findings and results in uncertainty about the safety and efficacy of many cardiovascular therapies in female patients. Recent Findings: Several barriers impact women’s participation in clinical trials, including enrollment criteria, common misconceptions, access to tertiary care, and women representation in clinical trial leadership. Summary: This short review discusses these barriers and suggests potential solutions to increase women’s participation in clinical trials and improve their cardiovascular health.

Original languageEnglish
Pages (from-to)885-888
Number of pages4
JournalCurrent Atherosclerosis Reports
Issue number11
StatePublished - Nov 2022


  • Cardiovascular health
  • Clinical trials
  • Equity
  • Women


Dive into the research topics of 'Best Practices for Designing Informative Trials Including Women'. Together they form a unique fingerprint.

Cite this